SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-126407
Filing Date
2024-11-13
Accepted
2024-11-13 16:34:24
Documents
70
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q stro-20240930.htm   iXBRL 10-Q 2951677
2 EX-31.1 stro-ex31_1.htm EX-31.1 15262
3 EX-31.2 stro-ex31_2.htm EX-31.2 15373
4 EX-32.1 stro-ex32_1.htm EX-32.1 7468
5 EX-32.2 stro-ex32_2.htm EX-32.2 7498
  Complete submission text file 0000950170-24-126407.txt   10686360

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT stro-20240930.xsd EX-101.SCH 1434915
72 EXTRACTED XBRL INSTANCE DOCUMENT stro-20240930_htm.xml XML 1962773
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38662 | Film No.: 241454991
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)